Prioritising the most needed paediatric antiretroviral formulations: the PADO4 listMartina Penazzato, Moherndran Archary, Tim R. Cressey et al.|The Lancet HIV|2019Cited by 61
Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescentsStéphane Blanche, Sabrina Spinosa‐Guzman, Rosa Bologna et al.|AIDS|2009Cited by 52
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trialAnna Turkova, Cecilia L. Moore, Karina Butler et al.|PLoS ONE|2018Cited by 29